Shuran Tan - Publications

Comparison of long-term survival between primary and interval cytoreductive surgery in advanced ovarian cancer: A ten-year real-world cohort study.

Journal: European journal of surgical oncology : the journal of the European Society of Surgical Oncology and the British Association of Surgical Oncology

Published: March 09, 2026

MAP2K6 reprograms NAD+ metabolism via the HMGA1-NAMPT axis to sensitize ovarian cancer cells to PARP inhibition.

Journal: Cell death & disease

Published: January 22, 2026

Prognostic Nomogram for Ovarian Cancer Patients on First-Line Maintenance Therapy With PARP Inhibitors: A Retrospective Cohort Study.

Journal: Cancer medicine

Published: September 04, 2025

Dual Targeting of Mutant p53 and SNRPD2 via Engineered Exosomes Modulates Alternative Splicing to Suppress Ovarian Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 16, 2025

Efferocytosis-Driven Polyamine Metabolism in Macrophages Enhances Cancer Stem Cell Enrichment after Chemotherapy in Ovarian Cancer.

Journal: Advanced science (Weinheim, Baden-Wurttemberg, Germany)

Published: July 05, 2025

HELQ upregulates PARP1 to drive platinum resistance and predict therapeutic response in ovarian cancer.

Journal: Translational oncology

Published: September 24, 2024

Omental cancer-associated fibroblast-derived exosomes with low microRNA-29c-3p promote ovarian cancer peritoneal metastasis.

Journal: Cancer science

Published: October 07, 2022

TIE2-high cervical cancer cells promote tumor angiogenesis by upregulating TIE2 and VEGFR2 in endothelial cells.

Journal: Translational oncology

Published: March 21, 2022

Tumor cell-derived exosomes deliver TIE2 protein to macrophages to promote angiogenesis in cervical cancer.

Journal: Cancer letters

Published: October 21, 2021

Association of smoking with risk of stroke in middle-aged and older Chinese: Evidence from the China National Stroke Prevention Project.

Journal: Medicine

Published: November 22, 2018